Loading...
Definitive Analysis

Financial Statements

Periods / Units / Analysis

Ticker

Industry

Sector

Page: Company Financials

Chi Sheng Pharma & Biotech Co., Ltd

Ticker: 4111.TWO | Industry: Medical - Instruments & Supplies | Sector: Healthcare
$29.70 -0.20 (-0.67%)
As of: 2026-01-23

Master Data Export


Enterprise Value

Metric 2025 2024 2023
Stock Price 29.64 26.47 26.36
Market Capitalization 1,721.24M 1,510.35M 1,511.60M
(-) Cash & Equivalents 355.33M 369.13M 408.49M
(+) Total Debt 125.63M 239.20M 212.87M
Enterprise Value 1,491.54M 1,380.42M 1,315.98M

Income Statement

Metric TTM TTM-1 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue 1,361M 1,104M 1,165M 1,061M 1,143M 1,022M 979M 1,023M
Cost of Revenue 831M 745M 768M 718M 721M 666M 656M 683M
Gross Profit 530M 359M 397M 343M 423M 357M 323M 340M
Gross Profit Margin 39.0% 32.5% 34.1% 32.3% 37.0% 34.9% 33.0% 33.3%
R&D Expenses 17M 19M 18M 22M 20M 19M 18M 21M
SG&A Expenses 320M 267M 280M 260M 249M 219M 229M 232M
Operating Expenses 337M 286M 298M 282M 269M 238M 247M 253M
Operating Income (EBIT) 193M 73M 99M 61M 154M 119M 76M 87M
Operating Income Margin 14.2% 6.7% 8.5% 5.8% 13.5% 11.6% 7.7% 8.5%
Interest Income 9M 12M 15M 14M 1M 0M 2M 1M
Interest Expense 1M 2M 2M 1M 2M 1M 0M 0M
Net Interest Income 8M 10M 13M 13M 0M -1M 2M 1M
Unusual Items 6M 7M 26M 13M 9M 13M 4M 9M
EBT Excluding Unusual Items 201M 84M 112M 74M 154M 118M 77M 88M
Pre-Tax Income 207M 91M 138M 87M 162M 132M 81M 97M
Pre-Tax Margin 15.2% 8.2% 11.8% 8.2% 14.2% 12.9% 8.3% 9.5%
Income Tax Expense 42M 19M 27M 19M -17M 24M 22M 25M
Net Income 165M 71M 111M 69M 154M 81M 59M 72M
Net Income Margin 12.1% 6.5% 9.5% 6.5% 13.5% 7.9% 6.0% 7.1%
Depreciation & Amortization 72M 59M 65M 62M 73M 79M 84M 83M
EBITDA 265M 133M 164M 123M 227M 198M 160M 170M
EBITDA Margin 19.5% 12.0% 14.1% 11.6% 19.8% 19.4% 16.3% 16.6%
NOPAT 154M 58M 79M 48M 170M 97M 55M 65M
NOPAT Margin 11.3% 5.3% 6.8% 4.5% 14.9% 9.5% 5.6% 6.4%
Owner's Earnings 140M 40M 91M 29M 121M -106M 120M 118M
Owner's Earnings Margin 10.3% 3.6% 7.8% 2.7% 10.6% -10.3% 12.3% 11.5%
EPS (Basic) 2.86 1.25 1.94 1.21 2.70 1.42 1.04 1.27
EPS (Diluted) 2.86 1.24 1.93 1.20 2.69 1.41 1.03 1.27
Shares (Basic) 58M 57M 57M 57M 57M 57M 57M 57M
Shares (Diluted) 58M 57M 57M 57M 57M 57M 57M 57M

Balance Sheet

Metric MRQ MRQ-1 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Cash & Cash Equivalents 421.85M 322.83M 336.19M 381.05M 456.25M 252.27M 335.80M 275.20M
Short-Term Investments 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Cash & Short-Term Investments 421.85M 322.83M 336.19M 381.05M 456.25M 252.27M 335.80M 275.20M
Net Receivables 350.01M 384.66M 327.32M 309.71M 283.30M 282.20M 248.78M 283.81M
Inventory 100.53M 95.12M 96.85M 89.17M 99.03M 90.25M 85.39M 85.52M
Other Current Assets 24.37M 29.33M 17.77M 19.96M 17.48M 17.63M 1.01M 0.82M
Total Current Assets 896.76M 831.94M 778.13M 799.89M 856.06M 642.36M 670.97M 645.34M
Property, Plant & Equipment 767.44M 805.88M 761.86M 734.99M 792.81M 903.70M 721.21M 775.78M
Goodwill 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Intangible Assets 1.63M 1.41M 1.63M 1.46M 1.04M 0.90M 0.97M 1.20M
Long-Term Investments 222.14M 185.39M 1.81M 1.84M 3.48M 0.00M 0.00M 0.00M
Tax Assets 4.00M 5.55M 11.23M 35.54M 54.20M 6.10M 7.98M 9.59M
Other Non-Current Assets 5.46M 5.10M 188.49M 188.28M 91.36M 97.61M 72.96M 78.43M
Other Assets 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Total Non-Current Assets 1,000.67M 1,003.33M 965.01M 962.10M 942.89M 1,008.30M 803.12M 864.99M
Total Assets 1,897.43M 1,835.27M 1,743.14M 1,761.99M 1,798.95M 1,650.66M 1,474.10M 1,510.33M
Accounts Payable 198.99M 132.83M 80.96M 226.33M 75.04M 57.54M 52.78M 58.60M
Short-Term Debt 37.19M 105.22M 169.31M 120.00M 281.99M 130.00M 136.03M 157.54M
Tax Payables 26.55M 17.25M 1.00M 1.20M 18.70M 14.01M 9.98M 18.97M
Deferred Revenue 0.00M 0.00M 0.00M 0.00M 115.89M 99.67M 93.80M 96.76M
Other Current Liabilities 191.01M 175.69M 105.51M 103.00M 95.29M 230.82M 76.23M 78.61M
Total Current Liabilities 453.74M 430.99M 356.79M 450.53M 586.90M 532.04M 368.83M 410.48M
Long-Term Debt 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M -30.28M
Capital Lease Obligations 15.49M 18.78M 16.62M 2.90M 8.38M 14.00M 12.53M 15.21M
Deferred Tax Liabilities 76.81M 76.55M 79.94M 0.00M 77.85M 76.52M 76.52M 76.52M
Other Non-Current Liabilities 9.73M 9.91M 15.25M 94.81M 6.84M 8.41M 8.99M 9.71M
Total Non-Current Liabilities 102.03M 105.24M 111.81M 97.71M 93.07M 98.94M 98.05M 71.16M
Total Liabilities 555.77M 536.23M 468.60M 548.24M 679.97M 630.98M 466.87M 481.64M
Preferred Stock 0.00M 0.00M 0.00M 0.00M 1.16M 0.00M 0.00M 0.00M
Common Stock 598.32M 598.32M 569.83M 569.83M 569.83M 569.83M 569.83M 569.83M
Retained Earnings 423.16M 378.03M 401.26M 603.19M 345.06M 254.90M 233.08M 249.04M
Accumulated OCI 0.00M 0.00M 0.00M 0.00M -1.16M 0.00M 0.00M 0.00M
Minority Interest 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Total Shareholders’ Equity 1,021.48M 976.35M 971.09M 1,173.02M 914.89M 824.73M 802.91M 818.87M
Total Equity 1,021.48M 976.35M 971.09M 1,173.02M 914.89M 824.73M 802.91M 818.87M
Total Liabilities & Equity 1,577.25M 1,512.58M 1,439.69M 1,721.25M 1,594.87M 1,455.71M 1,269.78M 1,300.51M
Tangible Assets 1,895.80M 1,833.87M 1,741.51M 1,760.53M 1,797.91M 1,649.77M 1,473.13M 1,509.14M
Tangible Equity 1,019.85M 974.95M 969.46M 1,171.56M 913.85M 823.84M 801.94M 817.68M
Tangible Book Value 1,019.85M 974.95M 969.46M 1,171.56M 913.85M 823.84M 801.94M 817.68M
Total Investments 222.14M 185.39M 1.81M 1.84M 3.48M 0.00M 0.00M 0.00M
Net Debt -384.66M -217.61M -166.88M -261.05M -174.26M -122.27M -199.77M -147.94M

Capital Metrics

Metric MRQ MRQ-1 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Working Capital 428.4M 381.4M 411.8M 352.5M 375.7M 204.6M 391.1M 332.3M
Total Capital 1,388.9M 1,415.1M 1,460.5M 1,342.0M 1,512.5M 1,392.9M 1,224.4M 1,244.6M
Capital Employed 1,429.0M 1,384.8M 1,376.8M 1,314.6M 1,318.6M 1,212.9M 1,194.2M 1,197.3M
Invested Capital 967.0M 1,092.2M 1,124.3M 960.9M 1,056.3M 1,140.7M 888.5M 969.4M

Cash Flow Statement

Metric TTM TTM-1 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Net Income 195.60M 86.65M 137.70M 68.67M 137.01M 104.83M 81.43M 97.26M
Depreciation & Amortization 72.23M 64.96M 65.12M 61.96M 72.88M 79.08M 84.14M 82.53M
Deferred Income Tax 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Stock-Based Compensation 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Change in Working Capital -51.14M 22.63M 7.79M -19.15M 25.45M -19.35M 5.41M -5.42M
Accounts Receivable -49.59M 11.73M -15.26M -26.60M -1.97M 0.00M 0.00M 0.00M
Inventory -2.24M -4.56M -7.68M 9.86M -8.83M -4.86M 0.13M -11.49M
Accounts Payable 0.00M -4.58M 0.00M -16.49M 17.50M 0.00M 0.00M 0.00M
Other Working Capital 0.70M 46.26M 30.73M 14.09M 36.25M 0.00M 0.00M 0.00M
Other Non-Cash Items 28.16M -3.80M 2.59M -36.97M 5.20M 0.12M 0.51M 2.69M
Net Cash from Operating Activities 244.85M 174.51M 213.20M 74.52M 214.86M 139.33M 143.53M 162.96M
Capital Expenditures (PPE) -96.59M -90.05M -84.19M -101.50M -105.85M -265.51M -22.79M -36.90M
Acquisitions (Net) 0.00M 0.36M 0.00M 0.00M 168.97M 0.00M 0.00M 0.00M
Purchases of Investments 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Sales / Maturities of Investments 0.00M 0.00M 0.00M 0.00M 0.00M 1.37M 0.00M 0.00M
Other Investing Activities -5.11M 0.87M -2.12M 24.88M 0.06M -25.00M 2.18M 0.22M
Net Cash from Investing Activities -101.70M -89.00M -86.31M -76.61M 63.24M -289.02M -20.56M -36.68M
Net Debt Issuance -162.13M -85.38M -110.00M -5.65M -7.03M 130.00M -6.44M -35.00M
Long-Term Debt Issuance 0.00M -1.83M 0.00M -5.65M -7.03M 0.00M -6.44M -5.73M
Short-Term Debt Issuance -162.13M -84.47M -110.00M 0.00M -10.00M 130.00M 0.00M -35.00M
Net Stock Issuance 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Common Stock Issuance 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Common Stock Repurchased 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Preferred Stock Issuance 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Net Dividends Paid 0.00M -56.98M -56.98M -68.38M -56.98M -56.98M -56.98M -34.19M
Common Dividends Paid 0.00M -56.98M -56.98M -68.38M -56.98M -56.98M -56.98M -34.19M
Preferred Dividends Paid 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M 0.00M
Other Financing Activities 120.79M 11.56M -4.77M 0.92M -10.87M -6.34M -0.01M -4.72M
Net Cash from Financing Activities -41.34M -139.74M -171.75M -73.11M -74.88M 66.68M -63.43M -73.91M
Effect of FX on Cash 0.00M 0.00M 0.00M 0.00M 0.77M -0.52M 1.07M -3.19M
Net Change in Cash 101.81M -54.23M -44.86M -75.21M 203.98M -83.53M 60.61M 49.19M
Cash at Beginning of Period 1,300.38M 1,575.62M 381.05M 456.25M 252.27M 335.80M 275.20M 226.01M
Cash at End of Period 1,402.19M 1,521.39M 336.19M 381.05M 456.25M 252.27M 335.80M 275.20M
Operating Cash Flow 244.85M 174.51M 213.20M 74.52M 214.86M 139.33M 143.53M 162.96M
Capital Expenditure -97.43M -90.92M -85.22M -101.50M -105.85M -265.51M -22.79M -36.90M
Free Cash Flow 147.41M 83.59M 127.98M -26.98M 109.00M -126.18M 120.74M 126.06M

Free Cash Flow

Metric TTM TTM-1 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
EBITDA 265.47M 132.79M 164.06M 123.17M 226.71M 198.14M 159.70M 169.74M
(-) Tax Adjustment 53.90M 28.00M 32.25M 26.32M 0.00M 36.20M 43.71M 43.30M
(-) Change In Working Capital -51.14M 22.63M 7.79M -19.15M 25.45M -19.35M 5.41M -5.42M
(-) Capital Expenditure -97.43M -90.92M -85.22M -101.50M -105.85M -265.51M -22.79M -36.90M
Unlevered Free Cash Flow 165.26M -8.75M 38.80M 14.51M 95.40M -84.23M 87.80M 94.97M
(-) Net Interest Income After Taxes 6.47M 8.19M 10.28M 10.21M -0.17M -0.55M 1.14M 0.77M
Net Debt Issuance -162.13M -85.38M -110.00M -5.65M -7.03M 130.00M -6.44M -35.00M
Levered Free Cash Flow -3.33M -102.32M -81.48M -1.35M 88.54M 46.32M 80.22M 59.20M